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ABSTRACT
Obesity in cats is associated with metabolic
abnormalities and increased susceptibility to diseases
such as diabetes mellitus. Studies in mouse models
and human beings have shown that probiotics can
reduce food intake, promote weight loss and improve
metabolic profile. Studies assessing the effects of
probiotics on these same parameters are absent in
cats. Therefore, the aim of this study was to determine
if probiotic Enterococcus faecium strain SF68 dietary
supplementation reduces food intake, promotes weight
loss and improves metabolic profile in overweight and
obese cats without comorbidities. Twenty overweight
and obese specific pathogen-free cats without
comorbidities were acclimatised to a dry diet for four
weeks. After exclusion of four cats for unrelated
reasons, eight cats received a daily oral probiotic for
eight weeks and eight control cats received no
probiotic. All cats were fed ad libitum with food intake
measured daily and bodyweight weekly. Blood was
collected at three time points: after four weeks of
acclimatisation to the diet, after eight weeks of
intervention and after six weeks of washout for
measurement of glucose, triglyceride, cholesterol,
fructosamine, insulin, leptin, total adiponectin and
deuterium oxide for body composition. There were no
differences in food intake, metabolic parameters and
body composition between the probiotic and control
groups after eight weeks of intervention and six weeks
of washout (P≥0.050). Short-term use of E faecium
SF68 dietary supplementation had no significant effect
on food intake, bodyweight, body composition or
metabolic parameters in overweight and obese specific
pathogen-free cats without comorbidities.
INTRODUCTION
The incidence of obesity in cats varies from
17 per cent to 63 per cent in developed coun-
tries (Kronfeld and others 1994, Allan and
others 2000, Cave and others 2012, Corbee
2014). Controlling calorie intake and adher-
ing to a weight loss programme is difficult for
many pet owners and prevention of weight
gain and reversal of obesity in cats is often not
successful. Excess bodyweight in cats is
related to several diseases such as diabetes
mellitus, hepatic lipidosis and osteoarthritis
(Scarlett and Donoghue 1998, German 2006,
German and others 2010). Therefore, it is
important that overweight and obese cats
achieve and maintain an ideal bodyweight,
necessitating investigation of the efficacy of
additional weight management strategies.
An imbalance in intestinal microbiota has
been associated with metabolic diseases such
as obesity, diabetes and atherosclerosis in
human beings (Kelsen and Wu 2012,
Moreno-Indias and others 2014, Nieuwdorp
and others 2014). In knockout and
diet-induced obese mice, obesity was asso-
ciated with changes in the composition and
metabolic function of the microbiome (Tilg
and others 2009). Similarly, one study docu-
mented that overweight and obese cats had a
significantly different gut microbiota com-
pared with lean cats (Kieler and others
2012). Another study reported that human
beings with low intestinal bacterial richness
were characterised by more marked adiposity,
insulin resistance and dyslipidaemia when
compared with human beings with high
intestinal bacterial richness (Le Chatelier
and others 2013). Bacteria belonging to the
genera Lactobacillus and Bifidobacterium have
been reported to have many beneficial
effects on metabolic syndrome, such as
weight loss and improved glucose tolerance
in human beings and mouse models (Cani
and others 2008, F S Teixeira and others
2013). In addition, a study showed that faecal
Clostridium cluster IV increased significantly
and Clostridium cluster XIVa decreased after
bodyweight reduction in human beings
(Remely and others 2015).Therefore, pro-
moting changes in the intestinal microbiota
may play an important role in ensuring the
efficacy and success of obesity treatments.
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The addition of prebiotics and probiotics to the diet of
mice fed ad libitum is associated with decreased fat
stores, reduction in adipocyte size, decreased food con-
sumption and weight gain, modulation of microbiota,
increased glucose tolerance, decreased total cholesterol
and triglycerides, and reduction of low-grade inflamma-
tion (Aronsson and others 2010, Andersson and others
2010a, b, Takemura and others 2010, Everard and others
2011, Neyrinck and others 2012). Lactobacillus rhamnosus
CGMCC1.3724 has been demonstrated to help obese
women achieve sustainable weight loss, as well as reduce
circulating leptin levels (Sanchez and others 2014). One
study suggested that a weight loss diet and probiotic
yogurt, enriched with Lactobacillus acidophilus La5,
Bifidobacterium BB12 and Lactobacillus casei DN001 had
synergistic effects in reducing body fat and weight among
overweight and obese human beings (Zarrati and others
2014). In addition, consumption of probiotic yogurt has
been associated with a reduced risk of weight gain and
obesity as well as cardiovascular disease in an observa-
tional study in human beings (Astrup 2014). A study in
healthy dogs reported that oral application of Enterococcus
faecium strain EE3 decreased total blood lipid concentra-
tion and cholesterol concentrations were brought back
within reference range (Marcináková and others 2006).
Although studies have investigated the impact of probio-
tics on various parameters in cats with diarrhoea (Bybee
and others 2011), herpesvirus (Lappin and others 2009)
and chronic kidney disease (Rishniw and Wynn 2011); to
the author’s knowledge no studies have assessed probiotic
effect on food intake, bodyweight and composition, and
metabolic parameters in cats.
Therefore, the aims of this study were to evaluate the
effects of probiotic E faecium SF68 dietary supplementa-
tion on daily food intake, bodyweight, body composition
and concentrations of blood glucose, triglyceride, choles-
terol, fructosamine, insulin, leptin, and total adiponectin
concentrations in a population of overweight and obese
cats without comorbidities. The probiotic E faecium SF68
dietary supplementation used in this study is the only pro-
biotic that is licensed for use in cats and dogs in the
European Union. Additionally, it has been studied most
commonly in feline diseases (Lappin and others 2009,
Bybee and others 2011), has quality assurance based on
manufacturer’s guarantee, and a previous study verified
this product exceeded the claim for quantifiable viable
organisms (Weese and Martin 2011). However, this pro-
biotic is not of feline origin and is derived from healthy
human infants. The results of this current study will help
to determine if the probiotic E faecium SF68 might be a
useful component of weight management plans for cats.
METHODS
Cats
Twenty specific pathogen-free, naturally occurring over-
weight and obese cats without comorbidities, based on
absence of clinical signs and no abnormalities on phys-
ical examination, from a research colony at the
University of California-Davis were included in this study.
Cats were assigned a body condition score based on a
9-point scale (Laflamme 1997). Cats with a body condi-
tion score of 5.5/9 to 7/9 were considered overweight
and cats with a score of 8/9 to 9/9 were considered
obese. The facility maintains room temperatures
between 18°C and 24°C, and has a 14-hour light/
10-hour dark cycle. Cats were fed the same dry diet
(Purina Cat Chow Complete Formula dry cat food;
Nestle Purina PetCare Company, St Louis, Missouri,
USA; Energy content (metabolisable energy; Maine,
USA, calculated): 3873 kcal/kg, 926 kJ/kg, Caloric distri-
bution: 34.3 per cent protein, 31.9 per cent fat and 33.8
per cent carbohydrate ME (based on conversion of guar-
anteed analysis using modified Atwater factors)) during
the study that passed feeding trials in accordance with
guidelines established by the Association of American
Feed Control Officials for all life stages. Water was avail-
able at all times during the study with the exception of
being withheld for two hours before body composition
determination.
The cats were evenly allocated to two groups based on
bodyweight and body condition score. A coin was
flipped to randomly select which of the two groups
would receive the probiotic E faecium SF68 supplementa-
tion versus control, which consisted of no supplementa-
tion. The probiotic group consisted of six male neutered
cats and four female entire cats. The mean age of cats
in the probiotic group was eight years and five months
(range 4 years–12 years and 9 months) and the mean
bodyweight and body condition score at inclusion were
6.5 kg and 7/9 (range 5.3–10.2 kg and 5.5/9–9/9,
respectively). The control group consisted of two male
neutered cats, five female entire cats and three female
spayed cats. The mean age of cats in the control group
was nine years and eight months (range 3 years and
6 months–12 years and 8 months) and the mean weight
and body condition score were 6.8 kg and 7/9 (range
4.4–7.4 kg and 5.5/9–9/9, respectively).
Study protocol
During the study, each cat was individually housed with
a socialisation/enrichment period of four hours per day
(08.00 till 12.00), during which time they were group-
housed with free access to water only. During the four-
week acclimatisation period they were placed back into
individual housing after socialisation and fed ad libitum.
During the following eight-week intervention period
each cat in the probiotic group was given 1 g of pro-
biotic E faecium SF68 dietary supplement (Purina
Veterinary Diets FortiFlora Feline Nutritional
Supplement; Nestle Purina PetCare Company, St Louis,
Missouri, USA; Energy content (metabolisable energy,
calculated): 4 kcal/g.), based on manufacturers’ recom-
mendation (5×108 colony-forming units per gram,
according to the manufacturers’ guarantee) in 10 g of
food with 1 ml of tap water to facilitate mixing daily
when returned to their individual cages. During the
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same time each control cat was given 10 g of food with
1 ml of tap water. Once the cats consumed their 10 g of
food, they received additional food ad libitum. During
the eight-week intervention period, all cats in the pro-
biotic group were closely supervised to ensure they con-
sumed all probiotic each day. Eight weeks was selected
for the intervention period as studies in both mouse
models and human beings have shown beneficial effects
of probiotics on obesity and metabolic parameters fol-
lowing supplementation for this length of time
(Agerholm-Larsen and others 2000, Everard and others
2011, Zarrati and others 2013, Wu and others 2015).
During the following six-week washout period, the same
protocol used for acclimatisation was applied. Six weeks
were deemed adequate for the washout period, as
studies have shown that probiotics do not persist in the
faeces after a few weeks following their discontinuation
(Goldin and others 1992, Spanhaak and others 1998,
Jacobsen and others 1999). Food intake (grams/day)
was measured daily and bodyweight with body condition
score assessed weekly during the three time periods for
all cats by the same investigator (AK). The study proto-
col was approved by the University of California-Davis
Institutional Animal Care and Use Committee (Animal
Welfare Assurance Number A3433-01) and complied
with the recommendations of the National Research
Council Guide for the Care and Use of Laboratory
Animals.
Collection of blood samples
At the end of the acclimatisation, intervention and
washout periods, food was withheld overnight for
12 hours. The following morning, each cat was weighed.
Water was withheld from the cats and two hours later
6 ml of blood was collected by venepuncture. The cats
were injected subcutaneously with their individually cal-
culated dose of deuterium oxide (D20; tracer dose of
0.4 g/kg) and three hours later 2 ml of blood was col-
lected by venepuncture.
Analysis of blood samples
Blood collected before administration of D20 was
allowed to clot at room temperature for 20 minutes fol-
lowed by centrifugation (room temperature, 2000 g for
10 minutes) and separation of serum into four micro-
tubes (E&K Scientific, Santa Clara, California, USA); the
first sample was submitted to the University of
California-Davis Veterinary Medical Teaching Hospital
Diagnostic Laboratory for measurement of glucose, tri-
glyceride, cholesterol and fructosamine. An automated
analyser (Cobas c501 analyzer, Hoffman-La Roche,
Basel, Switzerland) was used to measure glucose, trigly-
ceride and cholesterol; fructosamine was measured
using a multispecies colorimetric assay incorporating
nitroblue-tetrazolium reagent base with an immunoana-
lyser (Olympus AU5400 Chemistry Immuno Analyzer.
Olympus America, Center Valley, Pennsylvania, USA).
The second sample was submitted to the Diagnostic
Center for Population and Animal Health at Michigan
State University for measurement of insulin using a mul-
tispecies radioimmunoassay (RIA) kit (EMD Millipore,
Billerica, Massachusetts, USA). The third sample was
submitted to the University of California-Davis
Department of Nutrition for measurement of leptin and
total adiponectin concentrations. Total adiponectin was
measured using a rat/mouse ELISA kit (B-Bridge,
Cupertino, California, USA) and leptin was measured
using a multispecies RIA kit (EMD Millipore, Billerica,
Massachusetts, USA). Both assays have been previously
validated for measuring total adiponectin and leptin in
feline samples (Wei and others 2014). The fourth
sample was sent to the University of Missouri for analysis
of D20. Enrichment of D20 in serum was used to calcu-
late total body water, lean body mass and fat mass using
a previously described D20 isotopic dilution method
(Backus and others 2010); water was distilled from
serum (Backus and others 2000) and deuterium enrich-
ment in water was determined using Fourier transform
infrared spectrometry (Jennings and others 1999). Body
fat mass was estimated as the difference between body-
weight and lean body mass, where the latter was esti-
mated from body water mass indicated by deuterium
dilution in serum water (lean body mass=body water
mass/0.72 (Wolfe 1984).
Statistical analysis
Analyses were performed using a computer software
package (Stata IC/V.13.1, StataCorp LP, College Station,
Texas, USA). Data were assessed for normality using the
Shapiro-Wilk test. Data were analysed using mixed-effects
analysis of variance to account for the repeated mea-
sures. Effects of group were evaluated at individual time
points or periods (time point 1: after a four-week period
of acclimatisation, time point 2: after an eight-week
period of intervention and time point 3: after a six-week
period of washout); effects of time were evaluated separ-
ately by group; this was done by creating separate
models evaluating the main effect of group at each time
point, and by creating separate models evaluating the
main effect of time for each group separately. The
repeated measures were handled by designating the
individual as the random effect. Post hoc contrasts were
adjusted for multiple comparisons using a Bonferroni
correction. Pearson correlation between continuous vari-
ables was estimated using linear regression with robust
variance estimation to account for replicate values
within individuals. Differences in age and bodyweight
between the two groups, at inclusion and after exclusion
of necessary cats was analysed using the Student’s t test.
Differences in body condition score between the two
groups, at inclusion and after exclusion of necessary cats
was analysed using the Mann–Whitney U test.
Differences in sex and neuter status between the two
groups, at inclusion and after exclusion of necessary cats
was analysed using the χ2 test. Statistical significance was
defined as P≤0.050 in all analyses.
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Data are presented as mean with se of the mean in
Figs 1 and 2 and mean with sd in Table 1.
RESULTS
No abnormalities were noted on the basis of prestudy
physical examinations before the four-week acclimatisa-
tion period or laboratory findings after the four weeks
of acclimatisation. Two cats were eliminated from the
probiotic group as one became febrile from suspected
cutaneous abscess on day 1 of the acclimatisation period
and the second cat developed diabetes mellitus on day
28 of the intervention period. Two cats were eliminated
from the control group; one became acutely anorexic
on day 24 of the acclimatisation period and was subse-
quently diagnosed with metastatic ovarian carcinoma.
The second cat became too fractious for blood collec-
tion and was also eliminated. Data from these four cats
were excluded from all analyses. The final probiotic
group consisted of eight cats (six male neutered and two
female entire). The mean age of cats in the probiotic
group was seven years and seven months (range 4 years–
12 years and 3 months) and the mean bodyweight and
body condition score at inclusion was 6.7 kg and 7/9
(range 5.3–10.2 kg and 6/9–9/9, respectively). The final
control group consisted of eight cats (two male neu-
tered, three female entire and three female neutered).
The mean age of cats in the control group was 10 years
and 2 months (range 5 years and 8 months–12 years and
8 months) and the mean weight and body condition
score was 5.7 kg and 6.5/9 (range 4.4–6.5 kg and 6/9–8/9,
respectively). There were no significant differences in
age, bodyweight or body condition score between the
two groups at inclusion (P>0.157), or after exclusion of
the four cats (P>0.155). All cats in the probiotic group
accepted and consumed all their daily amount of pro-
biotic E faecium SF68 dietary supplementation during
the eight-week period.
Comparisons between the control and probiotic groups
There was an almost significantly higher insulin concen-
tration in the probiotic group (80.8±17.50) compared
with the control group (65.8±15.14) at the end of the
four-week acclimatisation period (time point 1, Table 1,
P=0.050, Table 2). There was a trend (P<0.1) towards a
significant difference in body weight at time points 1
and 2, with the cats in the probiotic group being
heavier. Additionally, there was a trend towards a signifi-
cantly greater lean body mass of the cats in the probiotic
group at time point 1. There were no statistically signifi-
cant differences in the remaining measured parameters
(daily food intake, body condition score, fat mass per
cent, blood glucose, triglyceride, cholesterol, fructosa-
mine, leptin and total adiponectin concentrations)
between the probiotic and control groups at any of the
three time points (P> 0.10, Table 2).
Comparisons among the three time points within each
group
There was a decrease in average daily food intake during
time points 2 and 3, compared with time point 1, within
each group of cats (P<0.001, mean daily food intake
(grams/day): probiotic group; time point 1: 91.4, time
point 2: 83.3, time point 3: 76.9, control group; time
FIG 1: Comparison of blood glucose within and between
probiotic and control groups at the three time points. Line
graph of average blood glucose (mg/dl) for cats in the
probiotic Enterococcus faecium strain SF68 supplementation
group (n=8) and control (unsupplemented) group (n=8) at the
three time points (1, after four weeks of acclimatisation; 2,
after eight weeks of intervention; 3, after six weeks of
washout). Dots represent mean with lines representing se of
the mean. There was a trend (P=0.081) towards a significant
increase in blood glucose at time point 3 when compared with
time point 1 within the probiotic group
FIG 2: Comparison of body fat mass within and between
probiotic and control groups at the three time points. Line
graph of average body fat mass for cats in the probiotic
Enterococcus faecium strain SF68 supplementation group
(n=8) and control (unsupplemented) group (n=8) at the three
time points (1, after four weeks of acclimatisation; 2, after
eight weeks of intervention; 3, after six weeks of washout).
Dots represent mean with lines representing se of the mean.
There was a trend (P=0.089) towards an increase in per cent
body fat mass at time point 2 compared with time point 1
within the probiotic group
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TABLE 1: Descriptive results showing the means and sds of various parameters for the probiotic Enterococcus faecium strain SF68 supplementation group (eight cats)
and control group consisting of no supplementation (eight cats)
Probiotic group Control group
Time point 1*
mean (SD)
Time point 2†
mean (SD)
Time point 3‡
mean (SD)
Time point 1
mean (SD)
Time point 2
mean (SD)
Time point 3
mean (SD)
Daily food intake
(g/day)
91.4 (19.31) 83.3 (15.82) 76.9 (15.60) 83.9 (25.00) 70.9 (21.72) 74.2 (20.50)
Blood glucose (mg/dl) 87.0 (8.83) 90.4 (9.21) 99.8 (17.12) 82 (10.41) 87.3 (13.12) 90.6 (15.67)
Triglyceride (mg/dl) 69.5 (43.73) 77.0 (38.14) 77.3 (43.40) 79.4 (49.66) 72 (38.14) 90.5 (44.96)
Cholesterol (mg/dl) 149 .0 (38.60) 147.4 (38.31) 146.4 (42.30) 151.8 (28.01) 140.3 (18.22) 145.8 (20.72)
Fructosamine (umol/l) 208.8 (17.24) 201.8 (16.62) 209.8 (21.55) 214.0 (25.25) 200.1 (14.25) 197.3 (17.62)
Insulin (pmol/l) 80.8 (17.50) 96.0 (23.30) 88.6 (20.04) 65.8 (15.14) 79.5 (20.05) 79.4 (20.91)
Leptin (ng/ml) 10.5 (4.76) 12.5 (5.62) 13.6 (6.44) 9.3 (3.33) 10.4 (5.02) 10.3 (4.16)
Adiponectin (μg/ml) 1.7 (1.85) 1.4 (1.50) 1.5 (1.68) 2.1 (0.96) 1.9 (1.25) 1.7 (1.03)
Bodyweight (kg) 6.9 (1.58) 7.1 (1.63) 7.1 (1.65) 5.8 (0.88) 5.9 (1.20) 6.1 (1.33)
Body condition score 7.5 (0.98) 7.8 (1.04) 7.8 (1.04) 7.1 (0.58) 7.2 (1.41) 7.1 (1.55)
Lean body mass (kg) 4.5 (0.91) 4.1 (1.02) 4.6 (1.29) 3.7 (0.96) 3.7 (0.94) 4.0 (0.76)
Fat mass % 34.6 (7.80) 42.1 (7.09) 35.3 (6.47) 36.8 (13.51) 37.9 (11.73) 33.5 (6.64)
Time point 1 (after a four-week period of acclimatisation), time point 2 (after an eight-week period of intervention) and time point 3 (after a six-week period of washout)
*Time point 1: after a four-week period of acclimatisation
†Time point 2: after an eight-week period of intervention
‡Time point 3: after a six-week period of washout
TABLE 2: P values obtained from the mixed-effects ANOVA* analysis for parameters compared among and between probiotic (Enterococcus faecium strain SF68)
supplemented group (n=8 cats) and control group consisting of no supplementation (n=8 cats)
Probiotic v control
Mixed-effects ANOVA Probiotic group Control group
Time
point 1†
Time
point 2‡
Time
point 3§
Time point
2 v 1
Time point
3 v 1
Time point
3 v 2
Time point
2 v 1
Time point
3 v 1
Time point
3 v 2
Daily food intake 0.365 0.158 0.771 0.00 0.00 0.00 0.00 0.00 0.0
Blood glucose 0.268 0.556 0.233 1.0 0.081 0.312 1.0 0.487 1.0
Triglyceride 0.652 0.779 0.521 1.0 0.781 0.611 1.0 1.0 1.0
Cholesterol 0.862 0.612 0.968 1.0 1.0 1.0 0.836 1.0 1.0
Fructosamine 0.559 0.304 0.179 1.0 1.0 1.0 0.390 0.203 1.0
Insulin 0.050 0.105 0.334 1.0 1.0 1.0 0.214 0.214 1.0
Leptin 0.511 0.397 0.192 1.0 0.746 1.0 1.0 1.0 1.0
Adiponectin 0.575 0.374 0.759 1.0 1.0 1.0 1.0 1.0 1.0
Bodyweight 0.060 0.072 0.143 1.0 1.0 1.0 1.0 1.0 1.0
Body condition score 0.246 0.331 0.311 1.0 1.0 1.0 1.0 1.0 1.0
Lean body mass 0.055 0.292 0.226 1.0 1.0 1.0 1.0 1.0 1.0
Fat mass % 0.670 0.383 0.568 0.089 1.0 0.145 1.0 1.0 1.0
*ANOVA: analysis of variance with post hoc pairwise comparisons using a Bonferroni correction
†Time point 1: after a four-week period of acclimatisation
‡Time point 2: after an eight-week period of intervention
§Time point 3: after a six-week period of washout
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point 1: 83.9, time point 2: 70.9, time point 3: 74.2;
Tables 1 and 2). Within the probiotic group there was a
tend (P=0.081) towards a significant increase in blood
glucose at time point 3 when compared with time point
1 (Table 2 and Fig 1). Additionally, there was a trend
(P=0.089) towards an increase in per cent body fat mass
at time point 2 when compared with time point 1 within
the probiotic group (Table 2 and Fig 2). There were no
significant differences in the remaining measured para-
meters (bodyweight, body condition score, lean body
mass, triglyceride, cholesterol, fructosamine, insulin,
leptin and total adiponectin concentrations) for any of
the three time point comparisons within the probiotic
or control groups (P>0.145, Tables 1 and 2).
There were small significant positive correlations
between the following parameters when all cats were
analysed at all three time points; body fat mass and
blood glucose (P=0.043, r=0.179), body fat mass and
fructosamine (P=0.025, r=0.276) and body fat mass and
body condition score (P=0.002, r=0.400). There was a
significant negative correlation between body fat mass
and total adiponectin concentration (P=0.002, r=0.400).
DISCUSSION
The high incidence of obesity in pet cats is a growing
concern, and this problem is associated with serious dis-
eases. Studies in mice models and human beings have
shown that probiotics can reduce food intake, promote
weight loss and improve metabolic profile (Aronsson
and others 2010, Andersson and others 2010a, b,
Takemura and others 2010, Everard and others 2011,
Neyrinck and others 2012, Sanchez and others 2014,
Zarrati and others 2014); however, similar studies are
absent in cats. The study reported here did not identify
any significant change within or between the control
and probiotic E faecium SF68 supplementation group
with respect to bodyweight, body condition score, lean
body mass, fat mass per cent, blood glucose, cholesterol,
triglyceride, insulin, fructosamine, leptin and total adi-
ponectin concentrations after eight weeks of interven-
tion and six weeks after discontinuation. Although daily
food intake was significantly decreased after eight weeks
of intervention and six weeks after discontinuation com-
pared with the end of the four-week acclimatisation
period in both groups, there were no significant differ-
ences between groups at any of the three time points.
This effect within both groups was likely due to wide
variation in daily food intake or self-regulation of food
intake rather than probiotic supplementation.
This study showed a trend towards a significant
increase in fat mass and blood glucose in the probiotic
group after eight weeks of probiotic supplementation
and six weeks after discontinuation compared with the
end of the four-week acclimatisation period. Both para-
meters did not reach significance; this could have been
due to a small sample size resulting in an underpowered
study and therefore, the potential impact of probiotic
supplementation on body fat mass and blood glucose
cannot be definitively determined. Further studies are
needed to ascertain if probiotic supplementation in
overweight and obese cats without comorbidities results
in increased body fat mass and blood glucose.
In contrast to the findings of the present study, the
addition of prebiotics and probiotics to the diet of mice
fed ad libitum has been shown to be associated with
decreased fat stores, reduction in adipocyte size,
decreased food consumption and weight gain, modula-
tion of microbiota, increased glucose tolerance,
decreased total cholesterol and triglycerides and reduc-
tion of low-grade inflammation (Aronsson and others
2010, Andersson and others 2010a, b, Takemura and
others 2010, Everard and others 2011, Neyrinck and
others 2012). Probiotics belonging to Lactobacillus and
Bifidobacterium species have been studied most commonly
in obese human beings and have been reported to
reduce bodyweight (Ilmonen and others 2011, Mikirova
and others 2011, Kadooka and others 2013, Sanchez
and others 2014, Zarrati and others 2014, Minami and
others 2015). Although the exact underlying mechanism
remains unclear, one study showed a moderate increase
in plasma lipopolysaccharide coupled with a decreased
number of intestinal Bifidobacteria in mice fed a
fat-enriched diet, resulting in the onset of metabolic dis-
eases such as obesity and diabetes (Cani and others
2007a). One study adduced that the effect of
Bifidobacteria on energy and fat metabolism is strain
dependent (Yin and others 2010). Differences in pro-
biotic strain may explain why the results of this study may
be in contrast to a study in dogs, which reported that E
faecium strain EE3 decreased total blood lipid concentra-
tion and influenced cholesterol levels (Marcináková and
others 2006). Therefore, further research to determine
the therapeutic response of each bacterial type and strain
to treat or prevent obesity is needed and may explain why
results from this current study differ from what has been
shown in mice and human beings.
Apart from an almost significant increase in blood
insulin in the probiotic group at the end of the four-
week acclimatisation period there were no significant dif-
ferences in the remaining parameters between the pro-
biotic and control groups at any time point. Similarly, a
recent meta-analysis of four randomised clinical trials
suggested that probiotics given over a three to eight
week period might not affect bodyweight, body mass
index or visceral fat of obese human patients (Park and
Bae 2015). As there are multiple mechanisms potentially
involved in changing microbiota that influence adiposity,
a longer intervention period may be needed to see an
effect in both cats and human beings (Agerholm-Larsen
and others 2000, Sharafedtinov and others 2013, Zarrati
and others 2013, Lee and others 2014). To that effect,
collection of faecal samples before and after probiotic
intervention to investigate the effects of living probiotics
and to confirm changes in microbiota were not per-
formed in either of the four human studies or in this
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current study. While the intent of this preliminary study
was to simply determine if probiotic supplementation
would affect change in bodyweight, body condition
score or biochemical parameters, investigating changes
in the microbiota following probiotic intervention in this
current study may have been beneficial. A prior study
performed in kittens indicated that blood triglyceride
concentration was negatively correlated with faecal
Veillonellaceae and Bifidobacteriaceae, while faecal
Lactobacillaceae had a negative association with body-
weight and a positive association with blood leptin con-
centration (Hooda and others 2013). In addition the
lack of significance in this current study and in the
meta-analysis may have been due to the absence of con-
current restrictive control of food intake, which may be
especially important as one study showed synergism
between probiotic and food restriction on weight loss in
human beings (Zarrati and others 2014).
Other factors may also confound outcomes in studies
of probiotics and their impact on bodyweight and meta-
bolic parameters. For example, activity level may influ-
ence body composition but this was not investigated in
the studies used in the meta-analysis or in this current
study; therefore, future studies using activity collars on
cats to track and determine if activity could be a con-
founding factor should be considered. In addition, two
separate studies have shown that probiotics specifically
cause weight loss in women (Kadooka and others 2013,
Sanchez and others 2014); unfortunately the sample size
of the present study was too small to specifically look at
the effects of sex. If the effects of probiotic are specific
to female or male cats, this may explain the lack of sig-
nificance in this current study.
An important consideration for selection of a pro-
biotic is host species specification, as this has been
shown to be important for manifestation of beneficial
effects of the probiotic (Dunne and others 1999,
Ouwehand and others 2002). However, the current
study utilised probiotics that originated from healthy
human being infants instead of healthy cats. Therefore,
the lack of a significant finding in the present study may
have been because a probiotic derived specifically from
healthy cats was not used. This may also explain why
results from this current study may differ from what has
been shown in mouse models and human beings, where
species-specific probiotics were commonly used. Another
possible limitation of the current study is that it was per-
formed in specific pathogen-free cats. Although these
cats were naturally overweight or obese, they may have a
different microbiota compared with conventionally
raised cats (Ritchie and others 2010). Therefore, find-
ings from the current study may not be applicable to
client-owned cats. However, the previous study only
reported findings from one specific pathogen-free cat,
so it is difficult to know how applicable the findings are
to the present study or to such populations in general.
Blood leptin is known to correlate positively with body
fat mass in cats (Appleton and others 2000, Backus and
others 2000, Martin and others 2006, Hoenig and others
2007, 2013); however, this current study did not find an
association between leptin and body fat mass. This may
have been due to other confounding factors such as sex
or age of the cats, which have been shown to also effect
leptin concentration (Appleton and others 2000, Backus
and others 2007). Furthermore the small sample size of
the current study may have precluded any finding of a sig-
nificant positive association. Similarly, although previous
studies have shown a positive correlation between blood
insulin and body fat mass in cats (Hoenig and others
2013, Bjornvad and others 2014), this current study did
not show such an association. This again may have been
due to confounding factors of age and sex (Hoenig and
others 2011, Bjornvad and others 2014) or due to the
small sample size used in the current study. The findings
of a positive association between fat mass and fructosa-
mine in this study has been previously described (Gilor
and others 2010). In this current study, blood total adipo-
nectin concentration was negatively associated with body
fat mass in all cats similar to other reports (Hoenig and
others 2007, 2013, Ishioka and others 2009, Takashima
and others 2016). However, recent studies have reported
that the high molecular weight form in particular is asso-
ciated with adiposity in cats and human beings (Hara and
others 2006, Sinha and others 2007, Kaser and others
2008, Bjornvad and others 2014, Witzel and others 2015),
and is thus functionally more important; unfortunately
this was not assessed in this study.
In conclusion, short-term use of probiotic E faecium
SF68 dietary supplementation had no effect on food
intake, bodyweight, body composition or metabolic para-
meters in overweight or obese specific pathogen-free
cats without comorbidities. However further studies are
needed to assess the effect of a longer intervention
period, larger sample size, different types and strains of
probiotics, and concurrent calorie restriction on these
parameters. In addition, any significant findings need to
be confirmed in client-owned cats.
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